Innate gamma/delta T-cells during HIV infection: Terra relatively incognita in novel vaccination strategies?

Chiara Agrati, Gianpiero D'Offizi, Marie Lise Gougeon, Miroslav Malkovsky, Alessandra Sacchi, Rita Casetti, Veronica Bordoni, Eleonora Cimini, Federico Martini

Research output: Contribution to journalArticlepeer-review


Despite a long-lasting global effort, the Holy Grail quest for a protective vaccine, able to confer prevention to HIV infection, did not reach the hoped for results, nor seems able to do so in the near future. Since mucosal surfaces of the host serve as the main entry point for HIV, it seems now logical to switch from a systemic to a localized view of events, in order to reveal critical steps useful in designing new and different vaccination strategies. In this context, the recent description of the very early phases of infection, from the eclipse to the viremia peak phase, seems to define a point-of-no-return threshold after which the main HIV infection steps, i.e. the massive destruction of the CD4+CCR5+ cell pool, the destruction of the mucosal physical barrier, and the establishment of reservoir sanctuaries, have already been accomplished. Nevertheless, the underlying mechanisms, the timing, and the consequences of evasion mechanisms exploited by HIV are still under scrutiny. Innate immunity, as part of a rapid lymphoid stress surveillance system, is known to play a central role in host responses to many infectious agents. In particular, V

Original languageEnglish
Pages (from-to)3-12
Number of pages10
JournalAIDS Reviews
Issue number1
Publication statusPublished - Jan 2011


  • Antiviral response
  • Early HIV infection
  • Innate immunity
  • Mucosal immunity

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Innate gamma/delta T-cells during HIV infection: Terra relatively incognita in novel vaccination strategies?'. Together they form a unique fingerprint.

Cite this